

+1 (840) 200-9998

Silverleaf Medical Sciences Story
Silverleaf develops solutions to power next-generation heart failure management systems. The value that Silverleaf delivers to this market is the ability to dramatically improve the accuracy, sensitivity, and robustness of heart failure management for the purpose of reducing hospital admission and improve the quality of life for HF patients. Silverleaf’s technology enables the development of devices that will have extensive accessibility to patients and that will meet the demand for effectiveness of heart failure management. It is committed to providing software solutions for effective heart failure management that benefits 64.3 millions of heart failure patients worldwide.

Updates and News
Jan 25, 2023
We are proud to announce the additions of Dr. Leon Sun, Dr. Yichen Cao, Mr. Todd Eis and Dr. Cyril Rakovski to our leadership team. They will add significantly to our teams expertise as we gear up to the next phase of our clinical studies and product development.
Silverleaf News
Sep 20, 2022
Silverleaf is in the process of finalizing the research agreement and IRB with the Loma Linda Vetrans Administration hospital, and exploring collaboration with additional academic healthcare facilities.
Clinical Study
Mar 1, 2022
We are pleased that we have enrolled our first patient into the ADOPTS trial in partnership with PIH-Good Samaritan Hospital in Los Angeles.
Clinical Study

Our Partners





